Robert Berman, Chief Medical Officer at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 26,565 shares at $27.09 ($724K) on 2018-01-10, disclosed to the SEC on 2018-01-12.
Open-market sale of $724k BHVN by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.09 | 4,945 | $134K | 18.5% |
| 2 | $27.09 | 19,780 | $536K | 74.0% |
| 3 | $29.37 | 1,840 | $54K | 7.5% |
| Total | $27.25 avg | 26,565 | $724K | 100% |
| Filing → |
| BHVN | SELL | 2020-06-22 | $9.3M | — | Filing → |
| BHVN | SELL | 2019-12-31 | $13.3M | — | Filing → |
| BHVN | SELL | 2019-12-31 | $6.6M | — | Filing → |